Christophe LE TOURNEAU
Date of Birth: January 20, 1974
Nationality: French
Professional Address: Department of Drug Development and Innovation (D3i)
Institut Curie – 26, rue d’Ulm – 75005 Paris – France
Phone : +33-1-4432-4675
Facsimile : +33-1-5310-4041
E-mail : Christophe.LeTourneau@curie.fr
N° RPPS 10003987137
Education:
2007 PhD, Thesis of Sciences
2005 Certified in Medical Oncology
2003 MD, Thesis of Medicine
Position:
Since January 2018 : Head of the Department of Drug Development and Innovation (D3i), Institut Curie, Paris & Saint-Cloud, France
Since September 2016 : Professor of medicine – Versailles-Saint-Quentin-en-Yvelines University
Since November 2009 : Medical Oncologist, Clinical Trial Unit – Department of Medical Oncology, Institut Curie, Paris, France – Head of Early Phase Clinical Trials and Head & Neck Oncology
2007 – 2009 : Clinical Fellowship, Drug Development Program, Department of Medical Oncology (Pr Siu), Princess Margaret Hospital, Toronto, Canada
2005 – 2007 : Assistant Professor of Oncology, Paris VII University. Departement of Medical Oncology (Pr Raymond), Beaujon University Hospital, Clichy
2004 – 2005 : Assistant of Oncology, Department of Medical Oncology (Pr Pouillart), Institut Curie, Paris
2000 – 2004 : Resident, graduated MD in the Faculty and Hospitals of Strasbourg, training in medical oncology, radiotherapy and public health.
1994 – 2000 : Medical student, Paris V University
Committees:
- ASCO
- Member scientific program committee – Developmental therapeutics (2017 – 2019)
- Chair scientific program committee – Developmental therapeutics (2018)
- ESMO
- Member scientific program committee – Head & Neck (2014, 2017 & 2019)
- Member scientific program committee – Developmental therapeutics (2018)
- ICHNO
- Member scientific program committee – Head & Neck (2017)
- ESMO Asia
- Co-chair scientific program committee – Personalized Medicine (2017)
- Member scientific program committee – Head & Neck (2018)
Editorial activities:
JCO Precision Oncology: Member of the Editorial Board (2017 – )
Lancet Oncology: Member of the International Advisory Board (2018 – )
Publications: 120+
International talks: 60+